• Overview
  • Eligibility
  • More info
  • Locations

Use of Near Infrared Spectroscopy in Preterm Infants to Determine Patent Ductus Arteriosus Closure Following Medical Treatment (NCT03026192)

Using cerebral and renal near infrared spectroscopy monitoring to determine PDA closure in preterm infants after completing medical treatment for a hemodynamically significant PDA.
  • Device: near infrared spectroscopy
    Near infrared spectroscopy will be placed on infants both with and without hsPDA
    Ages eligible for Study
    up to 1 Weeks
    Genders eligible for Study
    All
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Inclusion Criteria:
    • preterm infants less than 32 weeks gestation
    Exclusion Criteria:
    • infection, congenital heart disease, syndromic anomalies, and perinatal asphyxia.

    1 locations

    United States (1)
    • Albany Medical Center Neonatal Intesive Care Unit
      recruiting
      Albany, New York, United States, 12208
    Status:
    recruiting
    Type:
    Observational
    Phase:
    -
    Start:
    30 November, 2016
    Updated:
    17 January, 2017
    Participants:
    40
    Apply
    A girl giving information about available additional trials.

    FindMeCure helps you find, understand and join clinical trials from all over the world.

    There are more clinical trials for your condition!